Genetic Engineering & Biotechnology News

APR15 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/806913

Contents of this Issue

Navigation

Page 22 of 37

If you are having trouble with a difficult-to-express protein, Selexis has breakthrough cell line development technologies that fundamentally impact and improve drug discovery, drug development and biopharmaceutical manufacturing. Proprietary Technologies for Addressing Secretion Bottlenecks Advanced Gene Expression Technologies Proprietary CHO-K1 Cell Line Proprietary Bioinformatics for Whole Genome Sequencing From difficult-to-express protiens to complex scaffolds, bi-specific antibodies and vaccines, the Selexis SUREtechnology Platform™ is the leading industry solution. www.selexis.com SUREtechnology Can Rescue Challenging Biologic Programs © Copyright 2017 Selexis SA. All Rights Reserved. GPCR image courtesy MolSoft

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - APR15 2017